RxSight (RXST) Stock: Buy, Sell, or Hold?
RXST - RxSight, Inc. Common Stock
$4.75
-0.15 (-3.06%)
▼
5d:
+0.42%
30d:
-32.05%
90d:
-15.33%
HOLD
LOW Confidence
Analysis Updated: Oct 1, 2026 12:00 AM ET
Earnings: Nov 04, 2026
Get Alerted When RXST Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: RXST shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: RXST shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: RXST is currently trading at $4.75, which is considered oversold relative to its 30-day fair value range of $4.97 to $6.65.
Technical Outlook: Technically, RXST is in a uptrend. The price is currently testing key support at $4.61. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.1% recently.
Market Sentiment: RXST scores 68/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $7.57 (+59.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, RXST is in a uptrend. The price is currently testing key support at $4.61. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.1% recently.
Market Sentiment: RXST scores 68/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $7.57 (+59.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$4.97 -
$6.65
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
91.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 0th percentile)
- BULLISH: Strong technical setup (68/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.1%)
- BULLISH: Trading 59.3% below Wall St target ($7.57)
- CAUTION: Bottoming setup, but lagging the sector by 45% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$4.97 -
$6.65
Current vs Trading Range
OVERSOLD
Expected Move (7 Days)
±$0.47
(9.9%)
Support & Resistance Levels
Support Level
$4.61
Resistance Level
$5.36
Current Trend
Uptrend
Technical data as of
Oct 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-6.81
Wall Street Target
$7.57
(+59.3%)
Revenue Growth (YoY)
0.3%
Profit Margin
-36.8%
Share & Embed Analysis
Last updated: October 02, 2026 3:18 AM ET
Data refreshes hourly during market hours. Next update: 4:18 AM
Data refreshes hourly during market hours. Next update: 4:18 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RXST showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$61 | 62 BUY |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$369 | 64 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$94 | 48 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$105 | 52 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$172 | 44 HOLD |
